中德临床肿瘤学杂志（英文版）
中德臨床腫瘤學雜誌（英文版）
중덕림상종류학잡지（영문판）
THE CHINESE-GERMAN JOURNAL OF CLINICAL ONCOLOGY
2014年
3期
144-145
,共2页
castration-resistant prostate cancer (CRPC)%treatment%traditional cytotoxic regimen
Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that recurs while a patient is receiving androgen deprivation therapy (ADT). Many treatment options have been suggested for this chal enging disease;starting from 2-year hormonal manipulations, mitoxantrne-and docetaxel-based regimens reaching to the overwhelming new systemic op-tions for CRPC (newer hormonal treatments, cytotoxic chemotherapies, bone-targeted agents and immunotherapeutics);and the question is:do the traditional cytotoxic regimens stil have a role amidst al these new options?
